Home Banner Ad
Beijing-based cancer diagnosis and therapy startup, Genecast secures RMB128 million (about US$18 million) in a series B round led by THG Ventures, a venture capital arm of Tsinghua Holdings.
Botworx.ai, the platform for authentic conversational commerce, has announced the closing of a US$3 million seed investment led by Costanoa Ventures with participation from SV Angel.
Huimin, a Beijing-based neighbourhood store startup has yesterday acquired Sequoia-backed Beequick, an online to offline delivery service. Financial details of the agreement were not disclosed.
Agribuddy provides a smartphones application to support rural farmers, providing them a free web service which credit sales of agricultural material and more.
Zhejiang-based Tianma Bearing Group Co., Ltd. and Southeast University Education Foundation have jointly invested RMB140 million (about US$20.35 million) in Diyi Chedai, a Shanghai-based auto lending start-up. with Phoneix Tree Capital as its exclusive financial advisor. This investment round is a Series B extension round that came just one month after the company raised RMB360 […]
Food Union Group, an international group of dairy and ice cream producing companies has received a combined US$225 million investment from PAG, one of Asia's largest private equity firms, and existing investor Meridian Capital.
InnerHour, an online psychological wellness platform, has raised US$450K in its first round of funding from financial advisory firm Batlivala & Karani Securities, investment firm Venture Works and others.
Cure App, a mobile solution to lifestyle-related diseases has managed to raised 380 million yen (about US$3.38 million) from Beyond Next, Keio Innovation Initiative, and SBI Investment. With the latest capitals, Cure App will strengthen its non-smoking cure applications.
Standard Charted Private Equity (SCPE) has acquired a majority stake in Siyanli, a Chinese beauty center operator. Post-acquisition, Zhu Wei will take the role of chairman at Siyanli.
Shanghai-based biotech startup Ark Biosciences has secured an undisclosed amount in a Series A extension funding led by Bioventure Investment Management, a Chinese medical and pharma-focused fund.